341 related articles for article (PubMed ID: 34342619)
1. Effect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial.
Barnhart KT; Hansen KR; Stephenson MD; Usadi R; Steiner AZ; Cedars MI; Jungheim ES; Hoeger KM; Krawetz SA; Mills B; Alston M; Coutifaris C; Senapati S; Sonalkar S; Diamond MP; Wild RA; Rosen M; Sammel MD; Santoro N; Eisenberg E; Huang H; Zhang H;
JAMA; 2021 Aug; 326(5):390-400. PubMed ID: 34342619
[TBL] [Abstract][Full Text] [Related]
2. Optimal treatment for women with a persisting pregnancy of unknown location, a randomized controlled trial: The ACT-or-NOT trial.
Barnhart KT; Sammel MD; Stephenson M; Robins J; Hansen KR; Youssef WA; Santoro N; Eisenberg E; Zhang H;
Contemp Clin Trials; 2018 Oct; 73():145-151. PubMed ID: 30243810
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.
van Mello NM; Mol F; Verhoeve HR; van Wely M; Adriaanse AH; Boss EA; Dijkman AB; Bayram N; Emanuel MH; Friederich J; van der Leeuw-Harmsen L; Lips JP; Van Kessel MA; Ankum WM; van der Veen F; Mol BW; Hajenius PJ
Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of health-related quality of life in women with ectopic pregnancy or pregnancy of unknown location treated with systemic methotrexate or expectant management.
van Mello NM; Mol F; Hajenius PJ; Ankum WM; Mol BW; van der Veen F; van Wely M
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():1-5. PubMed ID: 26125101
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta-analysis.
Solangon SA; Van Wely M; Van Mello N; Mol BW; Ross JA; Jurkovic D
Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1159-1175. PubMed ID: 37345445
[TBL] [Abstract][Full Text] [Related]
6. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
[TBL] [Abstract][Full Text] [Related]
7. Medical management of ectopic pregnancy with single-dose and 2-dose methotrexate protocols: human chorionic gonadotropin trends and patient outcomes.
Mergenthal MC; Senapati S; Zee J; Allen-Taylor L; Whittaker PG; Takacs P; Sammel MD; Barnhart KT
Am J Obstet Gynecol; 2016 Nov; 215(5):590.e1-590.e5. PubMed ID: 27371354
[TBL] [Abstract][Full Text] [Related]
8. Single-dose versus two-dose administration of methotrexate for the treatment of ectopic pregnancy: a randomized controlled trial.
Song T; Kim MK; Kim ML; Jung YW; Yun BS; Seong SJ
Hum Reprod; 2016 Feb; 31(2):332-8. PubMed ID: 26701971
[TBL] [Abstract][Full Text] [Related]
9. Reproductive outcome after early miscarriage: comparing vaginal misoprostol treatment with expectant management in a planned secondary analysis of a randomized controlled trial.
Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
Ultrasound Obstet Gynecol; 2022 Jan; 59(1):100-106. PubMed ID: 34523740
[TBL] [Abstract][Full Text] [Related]
10. Clinical and psychological impact after surgical, medical or expectant management of first-trimester miscarriage--a randomised controlled trial.
Kong GW; Lok IH; Yiu AK; Hui AS; Lai BP; Chung TK
Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):170-7. PubMed ID: 23488984
[TBL] [Abstract][Full Text] [Related]
11. MisoREST: Surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: A cohort study.
Lemmers M; Verschoor MAC; Oude Rengerink K; Naaktgeboren C; Bossuyt PM; Huirne JAF; Janssen IAH; Radder C; Klinkert ER; Langenveld J; van der Voet L; Siemens FF; Bongers MY; van Hooff MH; van der Ploeg M; Sjors FPJ; Coppus SFPJ; Ankum WM; Mol BWJ;
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():83-89. PubMed ID: 28209537
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study.
Lemmers M; Verschoor MAC; Bossuyt PM; Huirne JAF; Spinder T; Nieboer TE; Bongers MY; Janssen IAH; Van Hooff MHA; Mol BWJ; Ankum WM; Bosmans JE;
Acta Obstet Gynecol Scand; 2018 Mar; 97(3):294-300. PubMed ID: 29266169
[TBL] [Abstract][Full Text] [Related]
13. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial.
Lemmers M; Verschoor MA; Oude Rengerink K; Naaktgeboren C; Opmeer BC; Bossuyt PM; Huirne JA; Janssen CA; Radder C; Klinkert ER; Langenveld J; Catshoek R; Van der Voet L; Siemens F; Geomini P; Van Hooff MH; Van der Ploeg JM; Coppus SF; Ankum WM; Mol BW;
Hum Reprod; 2016 Nov; 31(11):2421-2427. PubMed ID: 27591236
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate versus expectant management in ectopic pregnancy: a meta-analysis.
Naveed AK; Anjum MU; Hassan A; Mahmood SN
Arch Gynecol Obstet; 2022 Mar; 305(3):547-553. PubMed ID: 34524502
[TBL] [Abstract][Full Text] [Related]
15. Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol.
Creinin MD
Am J Obstet Gynecol; 1996 Feb; 174(2):776-8. PubMed ID: 8623820
[TBL] [Abstract][Full Text] [Related]
16. Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial.
Jurkovic D; Memtsa M; Sawyer E; Donaldson AN; Jamil A; Schramm K; Sana Y; Otify M; Farahani L; Nunes N; Ambler G; Ross JA
Ultrasound Obstet Gynecol; 2017 Feb; 49(2):171-176. PubMed ID: 27731538
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Bilateral Uterine Artery Chemoembolization in Combination with Surgical Evacuation or Systemic Methotrexate for Cervical Pregnancy.
Chen H; Yang S; Fu J; Song Y; Xiao L; Huang W; Zhang H
J Minim Invasive Gynecol; 2015; 22(6):1029-35. PubMed ID: 26037963
[TBL] [Abstract][Full Text] [Related]
18. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis.
Sotiriadis A; Makrydimas G; Papatheodorou S; Ioannidis JP
Obstet Gynecol; 2005 May; 105(5 Pt 1):1104-13. PubMed ID: 15863551
[TBL] [Abstract][Full Text] [Related]
19. Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.
Verschoor MA; Lemmers M; Bossuyt PM; Graziosi GC; Hajenius PJ; Hendriks DJ; van Hooff MA; van Meurs HS; Opmeer BC; van Tulder MW; Bouwma L; Catshoek R; Geomini P; Klinkert ER; Langenveld J; Nieboer TE; van der Ploeg JM; Radder CM; Spinder T; van der Voet LF; Mol BW; Huirne JA; Ankum WM
BMC Pregnancy Childbirth; 2013 May; 13():102. PubMed ID: 23638956
[TBL] [Abstract][Full Text] [Related]
20. Resolution of hormonal markers of ectopic gestation: a randomized trial comparing single-dose intramuscular methotrexate with salpingostomy.
Saraj AJ; Wilcox JG; Najmabadi S; Stein SM; Johnson MB; Paulson RJ
Obstet Gynecol; 1998 Dec; 92(6):989-94. PubMed ID: 9840564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
